National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Understanding Cancer Series: Blood Stem Cell Transplants
< Back to Main
In English     En español
    Posted: 09/01/2006    Reviewed: 09/01/2006
Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Slide 13  :  Three Most Important Antigens <  >  

Some donor "self" antigens are more antigenic than others, which means they are better at triggering an unwanted immune reaction in the transplant patient. By studying successful cases of blood stem cell transplantations, doctors have identified the three most important antigens to match when choosing "non-self" donors for a transplant. Matching these helps to minimize the chances of graft vs. host or host vs. graft attacks. The antigens are HLA-A, HLA-B, and HLA-DR.

Three Most Important Antigens

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov